Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |